Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients
Medical trial finds ticagrelor–aspirin antiplatelet therapy more beneficial in persons with normal renal function
1 November 2022Birth cohort study reveals the mental health burden of trauma in childhood
1 November 2022Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients
A study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe quantification of cystic fibrosis transmembrane conductance regulator (CFTR) function and the extent of its pharmacologic improvement. The study is published in Annals of Internal Medicine.
